Breaking News Instant updates and real-time market news.

SFLY

Shutterfly

$41.24

-0.58 (-1.39%)

, MJ

ETFMG Alternative Harvest ETF

$35.62

0.01 (0.03%)

08:45
03/11/19
03/11
08:45
03/11/19
08:45

Largest borrow rate increases among liquid names

Latest data shows the largest indicative borrow rate increases among liquid option names include: Shutterfly (SFLY) 2.74% +2.30, iShares Goldman Sachs Software Index Fund (IGV) 3.43% +0.53, ETFMG Alternative Harvest ETF (MJ) 14.13% +0.46, Sears (SHLDQ) 119.80% +0.44, Turtle Beach (HEAR) 71.92% +0.21, ProShares Ultra (BOIL) 9.89% +0.21, Enlink Midstream (ENLC) 0.84% +0.11, Frontier Communications (FTR) 13.97% +0.06, SPDR Barclays Capital High Yield Bond (JNK) 2.04% +0.02, and Crispr Therapeutics (CRSP) 0.91% +0.02.

SFLY

Shutterfly

$41.24

-0.58 (-1.39%)

MJ

ETFMG Alternative Harvest ETF

$35.62

0.01 (0.03%)

HEAR

Turtle Beach

$15.45

-0.02 (-0.13%)

ENLC

EnLink Midstream

$11.26

-0.04 (-0.35%)

FTR

Frontier Communications

$2.69

-0.03 (-1.10%)

JNK

SPDR Barclays High Yield Bond

$35.39

-0.06 (-0.17%)

CRSP

Crispr Therapeutics

$37.87

-0.85 (-2.20%)

  • 14

    Mar

  • 19

    Mar

  • 01

    Apr

  • 01

    May

  • 07

    Aug

  • 06

    Nov

SFLY Shutterfly
$41.24

-0.58 (-1.39%)

02/06/19
BARD
02/06/19
NO CHANGE
Target $45
BARD
Neutral
Shutterfly near-term risks elevated, says Baird
Baird analyst Colin Sebastian said Shutterfly disappointed in its most important seasonal quarter. The analyst noted the consumer segment revenues were below guidance once again, and he believes there is increasing pressure on management to integrate LifeTouch with the core Shutterfly business through revenue synergies. He also said the pending departure of the company's CEO and the board's strategic review could distract from the company's current strategic direction. Sebastian maintained his Neutral rating and lowered his price target to $45 from $55 on Shutterfly shares.
02/06/19
RHCO
02/06/19
NO CHANGE
Target $55
RHCO
Buy
Shutterfly price target lowered to $55 from $70 at SunTrust
SunTrust analyst Youssef Squali lowered his price target on Shutterfly to $55 after its latest earnings miss. The analyst keeps his Buy rating on the shares however, noting that its announced strategic review committee formation and CEO departure are appropriate at this juncture, adding that its risk-reward profile of 6.5-times enterprise value to EBITDA is also "attractive".
02/04/19
02/04/19
INITIATION

Fly Intel: Top five analyst initiations
Catch up on today's top five analyst initiations with this list compiled by The Fly: 1. Yelp (YELP) initiated with a Buy at Goldman Sachs while Groupon (GRPN) was initiated with a Neutral, and Match Group (MTCH) and Shutterfly (SFLY) were initiated with a Sell. 2. eHealth (EHTH) initiated with an Outperform at Evercore ISI. 3. Okta (OKTA) initiated with an Equal Weight at Morgan Stanley. 4. Lonestar Resources (LONE) initiated with an Outperform at Cowen. 5. Kopin (KOPN) initiated with a Buy at Ladenburg. This list is just a portion of The Fly's analyst coverage. To see The Fly's full Street Research coverage, click here.
02/06/19
AGIS
02/06/19
NO CHANGE
Target $55
AGIS
Buy
Shutterfly investors' 'best bet' is to hang on in hopes for deal, says Aegis
Aegis analyst Victor Anthony said Shutterfly had an "eventful" evening yesterday, as the company reported revenue and adjusted EBITDA that missed his estimates, gave guidance that also missed his and consensus estimates, pushed out its synergy targets, announced the departure of its CEO and announced it had been approached about a potential acquisition and is exploring alternatives. Anthony, who notes that he previously highlighted Shutterfly as a potential acquisition target or the target of activist investors, believes that "the best bet for investors is to hang onto the shares in anticipation of an acquirer stepping in." A financial buyer could pay $60 per share, while a strategic acquirer could pay $70 per share, believes Anthony, who has a Buy rating and $55 price target on Shutterfly shares.
MJ ETFMG Alternative Harvest ETF
$35.62

0.01 (0.03%)

HEAR Turtle Beach
$15.45

-0.02 (-0.13%)

12/07/18
DADA
12/07/18
NO CHANGE
Target $30
DADA
Buy
Turtle Beach benefits from Fortnite Season 7 launch yesterday, says DA Davidson
DA Davidson analyst Tom Forte kept his Buy rating and $30 price target on Turtle Beach (HEAR), saying investors should buy the stock after the launch of the latest Fortnite season 7 yesterday. The analyst contends that Fortnite developer - Epic Games - has continued to refine the title over time, giving it "staying power" that's reflected by its 200M user milestone reached last month. Forte continues to anticipate the sustained Fortnite popularity to result in "elevated sales of gaming headsets", which should be positive news for Turtle Beach and Logitech (LOGI).
11/28/18
DADA
11/28/18
NO CHANGE
Target $30
DADA
Buy
Turtle Beach to benefit from continued popularity of Fortnite, says DA Davidson
DA Davidson analyst Tom Forte kept his Buy rating and $30 price target on Turtle Beach (HEAR), saying the recent Bloomberg article indicating 200M active Fortnite gamers - up from 125M in June - suggests that its popularity is not a "fad". The analyst believes that this growth should result in "elevated sales of gaming headsets, which should be positive news for Turtle Beach primarily and Logitech (LOGI) secondarily. Forte adds that the initial success of the latest Call of Duty title and Red Dead Redemption 2, which are also games with battle royale playing formats, will sustain demand for the Turtle Beach accessories.
11/26/18
WEDB
11/26/18
NO CHANGE
WEDB
Wedbush Black Friday checks positive for Consumer Electronics, Turtle Beach
Wedbush Retail analysts led by Michael Pachter say their Black Friday channel checks were positive for Consumer Electronics with Turtle Beach (HEAR) a "stand-out." Fitbit (FIT) and GoPro (GPRO) offered more compelling discounts on new products this year versus last year, which likely drove more unit sales, the analysts write in a research note. Further, they believe Amazon (AMZN) took Smart TV market share as its Fire TV Edition Smart TVs were not available at retail last year. Nonetheless, with more favorable pricing this year across brands and greater breadth of products, Roku TV (ROKU) unit sales were likely higher versus last year, say the analysts. And despite high inventory going into Black Friday, Turtle Beach had low inventory levels with "spotty" sell-outs on Black Friday, they note. The analysts believe this suggests a "very strong uptick" in year-over-year holiday sales for the company.
02/07/19
LSCM
02/07/19
NO CHANGE
LSCM
Turtle Beach releases better-than-expected Q4 preannouncement, says Lake Street
Lake Street analyst Mark Argento maintained a Buy rating and $40 price target on Turtle Beach, after the company's Q4 preannouncement was "significantly ahead" of both consensus estimates and the company's guidance. The analyst noted that Turtle Beach's market share expanded in FY18, that the company generated significant free cash flow in FY18, and that the company is expecting strong gross margin in Q4 and for FY18. Argento believes Turtle Beach's FY19 will be closer to FY18 than FY17, given the company's expansion and larger installed base of hardware.
ENLC EnLink Midstream
$11.26

-0.04 (-0.35%)

02/08/19
STFL
02/08/19
INITIATION
Target $13
STFL
Buy
EnLink Midstream initiated with a Buy at Stifel
Stifel analyst Timothy Howard started EnLink Midstream with a Buy rating and $13 price target. The company's valuation and long-term prospects, including asset repurposing, provide an attractive investment opportunity, says the analyst. He believes EnLink Midstream offers investors a 35% total return potential, including a 10% yield.
11/13/18
FBCO
11/13/18
UPGRADE
FBCO
Outperform
EnLink Midstream upgraded to Outperform from Neutral at Credit Suisse
12/20/18
JEFF
12/20/18
UPGRADE
Target $13
JEFF
Buy
EnLink Midstream upgraded to Buy from Hold at Jefferies
Jefferies analyst Christopher Sighinolfi upgraded EnLink Midstream to Buy while lowering his price target for the shares to $13 from $16. The analyst finds the Midstream & Refining attractive citing "simplified structures, reduced leverage, minimal equity need, and continued growth." U.S. Midstream and Refining equities are approaching year-end at multi-year lows with valuation multiples 15%-30% below three-year averages, Sighinolfi tells investors in a research note titled "Hey Nineteen, That's Real Opportunity." The analyst sees "supportive" 2019-2020 fundamentals and believes investors will find value in the sector. As such, he upgraded 10 names in the space.
11/13/18
11/13/18
UPGRADE
Target $19

Outperform
EnLink Midstream upgraded to Outperform at Credit Suisse
As previously reported, Credit Suisse analyst Spiro Dounis upgraded EnLink Midstream to Outperform from Neutral, with a $19 price target. The analyst notes that management enhanced earnings growth visibility, which appears very manageable, and points out that the stock has underperformed the MLP space. Additionally, he expects the simplified corporate structure and removal of IDRs to result in a wider investor base.
FTR Frontier Communications
$2.69

-0.03 (-1.10%)

02/19/19
RAJA
02/19/19
DOWNGRADE
RAJA
Market Perform
Frontier Communications downgraded to Market Perform at Raymond James
01/08/19
WELS
01/08/19
DOWNGRADE
Target $1.75
WELS
Underperform
Frontier downgraded to Underperform from Market Perform at Wells Fargo
Wells Fargo analyst Jennifer Fritzsche downgraded Frontier Communications (FTR) to Underperform and lowered her price target for the shares to $1.75 from $5.00. The analyst also downgraded the Rural Local Exchange Carrier sector to Underweight from Market Weight. Frontier has reportedly been working with an advisor on how it might handle upcoming debt maturities, Fritzsche tells investors in a research note. The debt seems to be pricing in a looming restructuring, which "could cause a scar on the RLEC industry," adds the analyst. Fritzsche remains concerned about Frontier's near term balance sheet obligations and believe "this is very much a debt story at this point."
02/19/19
RAJA
02/19/19
DOWNGRADE
RAJA
Market Perform
Frontier Communications downgraded to Market Perform at Raymond James
Raymond James analyst Frank Louthan downgraded Frontier Communications (FTR) to Market Perform from Outperform saying the negative Windstream (WIN) ruling will have a negative impact from a trading perspective. Louthan said rural ILECs tend to trade as a group and are overly correlated with each other regardless of their results.
01/08/19
WELS
01/08/19
DOWNGRADE
Target $11.25
WELS
Market Perform
Consolidated Communications downgraded to Market Perform at Wells Fargo
Wells Fargo analyst Jennifer Fritzsche downgraded Consolidated Communications to Market Perform from Outperform and lowered her price target for the shares to $11.25 from $13.50. The analyst also downgraded the Rural Local Exchange Carrier sector to Underweight from Market Weight. She believes Consolidated Communications has the ability to sustain its dividend. However, she is concerned that any sort of restructuring, or perception that a restructuring could occur with Frontier Communications (FTR), "could put a stain on the whole RLEC group." If Frontier has to do "some creative things" with its balance sheet, investors will look to who could be next and Consolidated Communications could be on that perceived list, Fritzsche tells investors in a research note.
JNK SPDR Barclays High Yield Bond
$35.39

-0.06 (-0.17%)

CRSP Crispr Therapeutics
$37.87

-0.85 (-2.20%)

02/07/19
PIPR
02/07/19
NO CHANGE
Target $75
PIPR
Overweight
Crispr Therapeutics sell-off 'unfounded,' Overweight reiterated at Piper Jaffray
Piper Jaffray analyst Edward Tenthoff reiterated an Overweight rating and $75 price target on Crispr Therapeutics (CRSP). In a research note to investors, Tenhoff noted that Crispr and the broader gene editing space are selling off in reaction to Sangamo's (SGMO) presentation of interim data from the first in vivo gene editing study at WORLD Symposium 2019, which showed no meaningful changes in IDS or GAG levels in six patients after 23 weeks. Tenthoff says he does not see read-through to Crispr and that he believes CTX001 ex vivo approach and biological rational of targeting fetal hemoglobin de-risk and differentiate Crispr and that he is a buyer on "unfounded" sell-off in shares.
02/07/19
BTIG
02/07/19
INITIATION
BTIG
Buy
Crispr Therapeutics initiated with a Buy at BTIG
BTIG analyst Amanda Murphy initiated Crispr Therapeutics with a Buy rating and $43 price target. Murphy sees Crispr as a front runner in the allogeneic pack, with its budding CAR-T pipeline. The analyst believes CTX001 represents under 5% of that price target, while the CAR-T franchise represents roughly 35%, and that the largest contribution comes from the value of the company's underlying platform, which accounts for slightly under 50% of the price target.
01/28/19
GSCO
01/28/19
DOWNGRADE
Target $40
GSCO
Neutral
Goldman downgrades Crispr Therapeutics to Neutral on lack of 2019 catalysts
Goldman Sachs analyst Salveen Richter downgraded Crispr Therapeutics to Neutral and cut his price target for the shares to $40 from $78. The stock closed Friday up 91c to $33.20. The analyst, while acknowledging Crispr "is a pioneer in the field of CRISPR/Cas9 gene editing," moves to the sidelines with the respect to the stock as he sees a lack of catalysts until the end of 2019. Further, he believes Bluebird Bio's (BLUE) gene therapy LentiGlobin has set a "high clinical hurdle and first-mover advantage" in transfusion-dependent beta-thalassemia and sickle cell disease. In addition, the allogeneic or "off-the-shelf" CAR T cancer field is getting "increasingly crowded with evolving timelines," Richter tells investors in a research note.
02/25/19
PIPR
02/25/19
NO CHANGE
Target $75
PIPR
Overweight
Crispr Therapeutics remains a top pick for 2019 at Piper Jaffray
Crispr Therapeutics (CRSP) ended Q4 with cash of $457M and the company and partner Vertex (VRTX) confirmed the first transfusion-dependent beta-thalassemia patient was dosed with CTX001, Piper Jaffray analyst Edward Tenthoff tells investors in a post-earnings research note. The analyst, who notes Crispr and the broader gene therapy/editing space are trading up in reaction to the Spark Therapeutics' (ONCE) acquisition by Roche (RHHBY), says Crispr remains a top pick for 2019. He believes the company's ex vivo approach and biological rational of targeting HbF de-risk and differentiate CTX001 from other gene editing players. The analyst reiterates an Overweight rating on Crispr with a $75 price target.

TODAY'S FREE FLY STORIES

APHA

Aphria

$7.64

-0.17 (-2.18%)

18:23
04/25/19
04/25
18:23
04/25/19
18:23
Hot Stocks
Green Growth Brands says offer for Aphria has expired »

Green Growth Brands…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ALGN

Align Technology

$296.77

-0.35 (-0.12%)

18:21
04/25/19
04/25
18:21
04/25/19
18:21
Hot Stocks
Align Technology CEO: We are enjoying good growth in North America »

In an interview on…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 09

    May

  • 15

    May

  • 05

    Jun

AAPL

Apple

$205.28

-1.82 (-0.88%)

18:21
04/25/19
04/25
18:21
04/25/19
18:21
Periodicals
Several veterans leave Apple's design team, WSJ reports »

Apple's design team…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 30

    Apr

  • 03

    Jun

FB

Facebook

$193.23

10.59 (5.80%)

18:18
04/25/19
04/25
18:18
04/25/19
18:18
Hot Stocks
Canadian agency says probe shows Facebook broke privacy law »

Canada's Office of…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Apr

  • 30

    May

  • 03

    Jun

NOV

National Oilwell

$26.44

-0.04 (-0.15%)

18:17
04/25/19
04/25
18:17
04/25/19
18:17
Earnings
National Oilwell reports Q1 EPS (20c), consensus (8c) »

Reports Q1 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Apr

  • 06

    May

  • 22

    May

  • 13

    Nov

FB

Facebook

$193.23

10.59 (5.80%)

18:16
04/25/19
04/25
18:16
04/25/19
18:16
Hot Stocks
Ireland's DPC opens statutory inquiry into Facebook »

Ireland's Data…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Apr

  • 30

    May

  • 03

    Jun

FB

Facebook

$193.23

10.59 (5.80%)

18:15
04/25/19
04/25
18:15
04/25/19
18:15
Hot Stocks
NY AG to investigate Facebook's collection of user email contact databases »

New York State Attorney…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Apr

  • 30

    May

  • 03

    Jun

AMZN

Amazon.com

$1,902.53

1.81 (0.10%)

18:09
04/25/19
04/25
18:09
04/25/19
18:09
Hot Stocks
Amazon.com says had 'a lot of good customer wins' in Q1 »

Says: Usage growth higher…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Apr

  • 10

    May

  • 22

    May

  • 03

    Jun

FIBK

First Interstate

$41.94

-0.63 (-1.48%)

18:08
04/25/19
04/25
18:08
04/25/19
18:08
Earnings
First Interstate reports Q1 EPS 69c, consensus 72c »

Reports Q1 provision for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Apr

  • 02

    May

F

Ford

$9.41

-0.17 (-1.77%)

18:03
04/25/19
04/25
18:03
04/25/19
18:03
Hot Stocks
Breaking Hot Stocks news story on Ford »

Ford says improving…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Apr

  • 25

    Apr

  • 01

    May

  • 03

    May

  • 09

    May

  • 24

    Jul

  • 23

    Oct

PUB

People's Utah Bancorp

$28.02

0.09 (0.32%)

18:01
04/25/19
04/25
18:01
04/25/19
18:01
Earnings
People's Utah Bancorp reports Q1 EPS ,55c consensus 55c »

Reports Q1 NII $26.91M,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Apr

  • 14

    May

  • 15

    May

AEGN

Aegion

$19.44

-0.58 (-2.90%)

17:57
04/25/19
04/25
17:57
04/25/19
17:57
Hot Stocks
Aegion subsidiary awarded three contracts valued at $13M total »

Aegion announced that its…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 02

    May

AMZN

Amazon.com

$1,902.53

1.81 (0.10%)

17:55
04/25/19
04/25
17:55
04/25/19
17:55
Hot Stocks
Amazon.com says will spend $800M in Q2 to move to one-day Prime delivery »

Says: Need to build out…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Apr

  • 10

    May

  • 22

    May

  • 03

    Jun

F

Ford

$9.41

-0.17 (-1.77%)

17:53
04/25/19
04/25
17:53
04/25/19
17:53
Hot Stocks
Ford CFO: Encouraged by progress made in China toward return to profitability »

Sees FY19 revenue growth,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Apr

  • 25

    Apr

  • 01

    May

  • 03

    May

  • 09

    May

  • 24

    Jul

  • 23

    Oct

CIR

Circor

$34.53

-2 (-5.48%)

17:48
04/25/19
04/25
17:48
04/25/19
17:48
Earnings
Circor sees Q2 adjusted EPS 40c-48c, consensus 54c »

Sees Q2 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Apr

  • 09

    May

F

Ford

$9.41

-0.17 (-1.77%)

17:48
04/25/19
04/25
17:48
04/25/19
17:48
Hot Stocks
Ford CFO says Q1 market share declined to 5.9% from 6.5% »

Says EBIT and EBIT margin…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Apr

  • 25

    Apr

  • 01

    May

  • 03

    May

  • 09

    May

  • 24

    Jul

  • 23

    Oct

CIR

Circor

$34.53

-2 (-5.48%)

17:46
04/25/19
04/25
17:46
04/25/19
17:46
Earnings
Circor reports Q1 adjusted EPS 38c, consensus 37c »

Reports Q1 revenue $270M,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Apr

  • 09

    May

F

Ford

$9.41

-0.17 (-1.77%)

17:45
04/25/19
04/25
17:45
04/25/19
17:45
Hot Stocks
Breaking Hot Stocks news story on Ford »

Ford sees over $1B in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Apr

  • 25

    Apr

  • 01

    May

  • 03

    May

  • 09

    May

  • 24

    Jul

  • 23

    Oct

ARGO

Argo Group

$74.21

-0.245 (-0.33%)

17:43
04/25/19
04/25
17:43
04/25/19
17:43
Upgrade
Argo Group rating change at William Blair »

Argo Group upgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 29

    Apr

  • 11

    Jun

ILMN

Illumina

$318.91

4.47 (1.42%)

17:36
04/25/19
04/25
17:36
04/25/19
17:36
Earnings
Illumina raises FY19 adj. EPS view to $6.63-$6.73 from $6.50-$6.60 »

Consensus $6.53. Backs…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Apr

  • 03

    May

  • 31

    May

  • 06

    Aug

  • 03

    Sep

HTH

Hilltop Holdings

$19.90

-0.19 (-0.95%)

17:35
04/25/19
04/25
17:35
04/25/19
17:35
Earnings
Hilltop Holdings reports Q1 EPS 41c, consensus 26c »

Hilltop's annualized…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Apr

F

Ford

$9.41

-0.17 (-1.77%)

17:35
04/25/19
04/25
17:35
04/25/19
17:35
Hot Stocks
Ford backs long-term revenue growth target view exceeding global GDP »

Backs FY19 long-term…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Apr

  • 25

    Apr

  • 01

    May

  • 03

    May

  • 09

    May

  • 24

    Jul

  • 23

    Oct

ILMN

Illumina

$318.91

4.47 (1.42%)

17:32
04/25/19
04/25
17:32
04/25/19
17:32
Earnings
Illumina reports Q1 adj. EPS $1.60, consensus $1.34 »

Reports Q1 revenue $846M,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Apr

  • 03

    May

  • 31

    May

  • 06

    Aug

  • 03

    Sep

GIB

CGI Group

$71.16

0.36 (0.51%)

17:30
04/25/19
04/25
17:30
04/25/19
17:30
Downgrade
CGI Group rating change at CIBC »

CGI Group downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 01

    May

ARGO

Argo Group

$74.21

-0.245 (-0.33%)

17:30
04/25/19
04/25
17:30
04/25/19
17:30
Upgrade
Argo Group rating change at William Blair »

Argo Group upgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 29

    Apr

  • 11

    Jun

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.